Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Switch From Efavirenz to Rilpivirine in Virologically-suppressed HIV-infected Thai Adolescents

NCT03033368 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT03033368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03033368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Switch From Efavirenz to Rilpivirine in Virologically-suppressed HIV-infected Thai Adolescents
Lead sponsor
Mahidol University
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2015
Completion date
December 31, 2017
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv